JUST RELEASED Massachusetts Biopharma Industry Snapshot 2012 – Top 10 Highlights

Today we released our annual Biopharma Industry Snapshot! Lots of good news for Massachusetts – you can read the full press release here and see the full snapshot here.

Here are the top 10 highlights:

1.  Industry Employment: 53, 253 – an all-time high. This accounts for over $6 billion in payroll.

2. Biotech R&D Jobs: Massachusetts leads the nation in R&D employment with over 28,000 positions in 2011.

3. Biotech R&D Industry Concentration: Massachusetts holds a dominant position in terms of industry concentration in “Biotechnology Research and Development” – almost twice the concentration of jobs as the next closest state:

4. Average Salary:  $113,364, 89.9% higher than the estimated state average salary.

5. Venture Investment: $1.071 billion in Massachusetts biotechs – an all-time high. Massachusetts received a greater percentage of total VC investment than peers across the US.

6. VC Deals: TESARO, Agios, and Merrimack were among the top 10 biotech VC deals globally in 2011. TESARO and Merrimack both have since had IPOs in 2012.

7. Manufacturing:  Massachusetts ran counter to the national declining trend, as one of only 5 of the leading biopharma manufacturing states that grew employment since 2002.

8. Drug Candidates: Massachusetts-headquartered companies have a total of 955 drug candidates at some stage of R&D. Oncology drug candidates make up 37% of that pipeline.

9. NIH Funded Hospitals: The top 5 NIH funded independent hospitals in the U.S. in 2011 are in Boston. Ten of the top 20 are in New England.

10. NIH Funding Per Capita: Massachusetts continues to far exceed other leading NIH-recipient states:
Compiled with support from EvaluatePharma

Read the full press release here.

See the full snapshot here.